Pan W H, Lai Y J, Chen N H
Institute of Pharmacology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan, Republic of China.
J Neurochem. 1995 Jun;64(6):2653-9. doi: 10.1046/j.1471-4159.1995.64062653.x.
Adult male Sprague-Dawley rats anesthetized with chloral hydrate and pentobarbital sodium were used as two different treatment groups. Conscious rats were used as a control group. By using baseline (precocaine) concentration as 100%, after cocaine administration (3.0 mg/kg i.v.), the maximal dopamine (DA) increase occurring at the first microdialysis collection period (20 min) in the medial prefrontal cortex was 299 +/- 46% for the chloral hydrate group, 168 +/- 12% for the pentobarbital sodium group, and 325 +/- 23% for the conscious group. At the same time, norepinephrine (NA) increases reached a maximum and were 162 +/- 20%, 100 +/- 5%, and 141 +/- 17%, respectively. The maximal changes of DA and NA in the chloral hydrate group and in the control group were both significantly higher than that in the pentobarbital sodium group. Meanwhile, the cocaine concentration was higher over a 100-min period of time in the chloral hydrate group when compared with the pentobarbital group and the control group. The peak cocaine concentration in dialysate occurred in the same time slot of maximal DA and NA responses, which were 0.65 +/- 0.08, 0.30 +/- 0.02, and 0.41 +/- 0.05 microM, respectively. Anesthetics suppress the pharmacologic response of neurons, which may explain the difference in catecholamine response between the pentobarbital sodium and the conscious groups. Conversely, because there was no significant difference in DA and NA response between the chloral hydrate group and the conscious group, it may possible be due to the balancing effect between the higher existing cocaine concentration and the anesthetic suppression on pharmacological response of neurons in the chloral hydrate group. The effect of guide cannula implantation on the cocaine-induced catecholamine response was also evaluated.
成年雄性Sprague-Dawley大鼠用氯水合醛和戊巴比妥钠麻醉,分为两个不同的治疗组。清醒大鼠作为对照组。以基线(可卡因前)浓度为100%,静脉注射可卡因(3.0mg/kg)后,内侧前额叶皮质在第一个微透析收集期(20分钟)多巴胺(DA)的最大增加量,氯水合醛组为299±46%,戊巴比妥钠组为168±12%,清醒组为325±23%。同时,去甲肾上腺素(NA)的增加量达到最大值,分别为162±20%、100±5%和141±17%。氯水合醛组和对照组中DA和NA的最大变化均显著高于戊巴比妥钠组。同时,与戊巴比妥组和对照组相比,氯水合醛组在100分钟内可卡因浓度更高。透析液中可卡因的峰值浓度出现在DA和NA反应最大的同一时间段,分别为0.65±0.08、0.30±0.02和0.41±0.05微摩尔。麻醉剂会抑制神经元的药理反应,这可能解释了戊巴比妥钠组和清醒组之间儿茶酚胺反应的差异。相反,由于氯水合醛组和清醒组之间DA和NA反应没有显著差异,这可能是由于氯水合醛组中较高的可卡因浓度与麻醉剂对神经元药理反应的抑制之间的平衡作用。还评估了引导套管植入对可卡因诱导的儿茶酚胺反应的影响。